Cereno Scientific has reported encouraging initial observations from the 12-month Expanded Access Program (EAP), reinforcing CS1’s favourable safety and tolerability profile across longer-term use. While based on a small dataset (n=10; six completing 12 months), we view the findings as supportive o
